Revogene C. difficile 410300
Revogene C. difficile 410300 (401300) is a clostridium difficile nucleic acid IVD (FDA Class II; FDA product code OZN, C. Difficile Toxin Gene Amplification Assay) made by Meridian Bioscience Inc., cleared under FDA 510(k) K172569 on 22 Nov 2017 and listed in FDA GUDID since 15 Jul 2020 (UDI-DI 00840733102349), active as of 8 Nov 2026. One FDA recall is linked to it.
Active
510(k)
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00840733102349 | Date15 Jul 2020 | StatusListed |
| United States | FDA 510(k)SESE | NumberK172569 | Date22 Nov 2017 | StatusActive |
Official records
- AccessGUDID record 00840733102349
- FDA 510(k) database K172569
Across registries
- FDA 510(k) K172569 decided 22 Nov 2017 Active
- FDA GUDID UDI-DI 00840733102349 listed 15 Jul 2020 Listed
Recalls
-
- Ongoing Z-1019-2026
The affected lots show a decline in performance over time, which may lead to false-negative results.
Timeline
- Cleared FDA 510(k) K172569
- Listed FDA GUDID 00840733102349
- Recall initiated FDA recalls Z-1019-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Revogene C. difficile
- Generic name
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- 410300, 401300
- Primary DI / UDI-DI
- 00840733102349
- 510(k) Number
- FDA product code
- OZN
- GMDN term
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class II
- Regulation number
- 866.3130
- GUDID distribution status
- In Commercial Distribution